Inovio Pharmaceuticals Statistics
Total Valuation
INO has a market cap or net worth of $64.53 million. The enterprise value is -$17.53 million.
Important Dates
The next estimated earnings date is Monday, May 12, 2025, after market close.
| Earnings Date | May 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
INO has 36.67 million shares outstanding. The number of shares has increased by 22.49% in one year.
| Current Share Class | 36.67M |
| Shares Outstanding | 36.67M |
| Shares Change (YoY) | +22.49% |
| Shares Change (QoQ) | +6.58% |
| Owned by Insiders (%) | 1.21% |
| Owned by Institutions (%) | 27.92% |
| Float | 33.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 220.78 |
| Forward PS | n/a |
| PB Ratio | 0.93 |
| P/TBV Ratio | 0.94 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.77, with a Debt / Equity ratio of 0.17.
| Current Ratio | 2.77 |
| Quick Ratio | 2.70 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -632.05 |
Financial Efficiency
Return on equity (ROE) is -115.42% and return on invested capital (ROIC) is -61.64%.
| Return on Equity (ROE) | -115.42% |
| Return on Assets (ROA) | -49.45% |
| Return on Invested Capital (ROIC) | -61.64% |
| Return on Capital Employed (ROCE) | -144.34% |
| Revenue Per Employee | $1,625 |
| Profits Per Employee | -$800,404 |
| Employee Count | 134 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -84.04% in the last 52 weeks. The beta is 1.84, so INO's price volatility has been higher than the market average.
| Beta (5Y) | 1.84 |
| 52-Week Price Change | -84.04% |
| 50-Day Moving Average | 1.90 |
| 200-Day Moving Average | 4.79 |
| Relative Strength Index (RSI) | 50.32 |
| Average Volume (20 Days) | 871,714 |
Short Selling Information
The latest short interest is 6.40 million, so 17.45% of the outstanding shares have been sold short.
| Short Interest | 6.40M |
| Short Previous Month | 5.35M |
| Short % of Shares Out | 17.45% |
| Short % of Float | 19.33% |
| Short Ratio (days to cover) | 9.03 |
Income Statement
In the last 12 months, INO had revenue of $217,756 and -$107.25 million in losses. Loss per share was -$3.95.
| Revenue | 217,756 |
| Gross Profit | -75.40M |
| Operating Income | -112.40M |
| Pretax Income | -121.64M |
| Net Income | -107.25M |
| EBITDA | -110.65M |
| EBIT | -112.40M |
| Loss Per Share | -$3.95 |
Full Income StatementBalance Sheet
The company has $94.11 million in cash and $11.87 million in debt, giving a net cash position of $82.25 million or $2.24 per share.
| Cash & Cash Equivalents | 94.11M |
| Total Debt | 11.87M |
| Net Cash | 82.25M |
| Net Cash Per Share | $2.24 |
| Equity (Book Value) | 68.50M |
| Book Value Per Share | 1.90 |
| Working Capital | 62.50M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$104.08 million and capital expenditures -$487,832, giving a free cash flow of -$104.56 million.
| Operating Cash Flow | -104.08M |
| Capital Expenditures | -487,832 |
| Free Cash Flow | -104.56M |
| FCF Per Share | -$2.85 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -51,616.91% |
| Pretax Margin | -49,254.27% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
INO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -22.49% |
| Shareholder Yield | -22.49% |
| Earnings Yield | -165.73% |
| FCF Yield | -161.57% |
Dividend DetailsAnalyst Forecast
The average price target for INO is $12.20, which is 593.18% higher than the current price. The consensus rating is "Buy".
| Price Target | $12.20 |
| Price Target Difference | 593.18% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 314.44% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on January 25, 2024. It was a reverse split with a ratio of 0.0833333:1.
| Last Split Date | Jan 25, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.0833333:1 |
Scores
INO has an Altman Z-Score of -21.34 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -21.34 |
| Piotroski F-Score | 1 |